| Document Date: 2012-05-29 09:30:37
Open Document File Size: 92,79 KBShare Result on Facebook
City New York / Paris / Lyon / / Company AMF / Sanofi / Crucell N.V. / Sanofi Pasteur / / Continent Asia / Africa / / Country France / / Currency EUR / / / Event Business Partnership / Company Listing Change / / IndustryTerm rabies treatment / final product / treatment for rabies / therapeutic solutions / immunoglobulin products / pharmaceutical / rabies products / / MedicalCondition well-established rabies / next generation rabies / rabies immunoglobulins / disease / human rabies / rabies / next-generation rabies / fatal disease / rabies monoclonal antibodies / infectious diseases / acute viral encephalitis / rabies MAbs / sanofi pasteur’s rabies / / MedicalTreatment immunization / passive immunization / active immunization / vaccination / / Organization World Health Organization / U.S. Securities and Exchange Commission / / Person Wayne Pisano / Louis Pasteur / Joseph Meister / Pascal Barollier / / / Position leader / President and Chief Executive Officer / Private / / Technology antibodies / SAN / therapeutic solutions / / URL http /
SocialTag |
Press release Sanofi Pasteur Lyon, France, January 3, 2008 Sanofi Pasteur: www.sanofipasteur.com Media Relations: Tel + [removed] Sanofi Pasteur Enters Agreement with